Worth Venture Partners »

Sage Therapeutics Inc call shares owned by Worth Venture Partners

Quarter-by-quarter ownership of Sage Therapeutics Inc call shares owned by Worth Venture Partners from 13F filings

Historical chart of Worth Venture Partners investment in Sage Therapeutics Inc call

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics Inc call held by Worth Venture Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics Inc call by Worth Venture Partners

Quarter filed Position value Share count Share price at filing
2024-06-30 $122k 215k 0.57

More positions owned by Worth Venture Partners

Johnson & Johnson (JNJ)
Weave Communications (WEAV)
Iteris (ITI)
Pfizer (PFE)
Radcom Shs New (RDCM)
Shotspotter (SSTI)
Viking Therapeutics (VKTX)
Cto Realty Growth (CTO)
Whitestone REIT (WSR)
Equity Comwlth Com Sh Ben Int (EQC)
Epr Pptys Com Sh Ben Int (EPR)
Plymouth Indl Reit (PLYM)
Moneylion Cl A (ML)
Sezzle (SEZL)
Alnylam Pharmaceuticals Call Call Option

View all positions for Worth Venture Partners

Top funds holding Sage Therapeutics Inc call

Worth Venture Partners
Simplex Trading
Group One Trading

View all funds holding Sage Therapeutics Inc call